Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma

Clinical trial NCT04903197 · TERMINATED

Trial details

NCT number

NCT04903197

Sponsor

Novartis Pharmaceuticals

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2022-01-24

Primary completion

2025-02-24

Enrollment

18

View on ClinicalTrials.gov